A private company striving to map the human genetic code reported today that it has completed a major step in the project - sequencing the genome.
Published:
7 April 2000 y., Friday
Celera Genomics of suburban Rockville, Md., said it has finished the sequencing phase of one person_s genetic code and will now begin to assemble the genetic fragments into their proper order.
The human genome is a biological map laying out the exact sequence of the estimated 3.5
billion pairs of chemicals that make up the DNA in each human cell. Those chemicals are
arranged in specific ways to create the estimated 80,000 to 100,000 human genes, which in
turn carry the instructions for all the body_s processes.
Understanding the massive series of genes that provide the code for life has been a major
project for both private and public organizations for several years, because it could serve as
the foundation for developing new medical cures and preventions.
Celera is a private company that is competing with government researchers to decode the
human genome. But to do so, it uses portions of the genome already sequenced by the nonprofit Human Genome Project, which posts on the Internet each bit of DNA it
completes decoding. The Human Genome Project has posted 2.3 billion subunits of DNA that it has decoded on the Internet for use by any scientist.
In contrast to how Celera sequences DNA, the Human Genome Project fits the genetic
puzzle pieces together as they are discovered, accumulating larger - and what it calls more
accurate - pieces. The Human Genome Project also expects to complete a ``working draft'' of the genome
later this year, and to publish a full genetic map on the Internet by 2003.
Copying, publishing, announcing any information from the News.lt portal without written permission of News.lt editorial office is prohibited.
The most popular articles
NASA on Thursday unveiled an ambitious plan to send eight or more probes to Mars over the next two decades to search for evidence of water or life.
more »
Cancer medication can be used for late-stage MS, says FDA
more »
In September alone, 29 new HIV cases were registered in Latvia, making a total of 302 new cases this year, according to the AIDS Prevention Center.
more »
Wheat plants grown in soil from near the Chernobyl nuclear power plant have six times the rate of mutations as those grown in clean soil, according to a study in this week's issue of Nature.
more »
Scientists believe fat plays an important role in helping the body to work properly.
more »
A rise in both the number of uninsured and out-of-pocket medical expenses has spurred several companies to form discount clubs that offer savings on prescription drugs, doctor visits and other medical services.
more »
Estonia will soon begin setting up one of the world's first country-wide gene banks where the detailed genetic codes of two-thirds of the population will be stored.
more »
For the first time in 50 million years, visitors to the North Pole can see something extraordinary: water.
more »
The first single-dose form of the drug most widely used to treat attention deficit disorder in children won U.S. government approval yesterday.
more »
People who use the Internet to find real-life sex partners are more likely to have had sexually transmitted diseases or engaged in risky intimate behavior, a government-led study found.
more »